细胞株Cell Lines 103及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV102
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID SV-E
AC CVCL_0C27
DR Cosmic; 2239091
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
RX PubMed=10100721;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SV-HCEC
AC CVCL_DQ72
SY SVHCEC
RX PubMed=9367354;
RX PubMed=11032886;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SV-HFO
AC CVCL_4T85
SY SVHFO; SV40-transformed Human Fetal Osteoblastic cells
RX CelloPub=CLPUB00294;
RX PubMed=8387478;
RX PubMed=15072557;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SV-HUC-1
AC CVCL_3798
SY HUC-1; SV-HUC; SVHUC
DR BTO; BTO:0003908
DR CLO; CLO_0009177
DR ATCC; CRL-9520
DR BCRC; 60358
DR BioSample; SAMN03471218
DR Cosmic; 687554
DR KCB; KCB 2012112YJ
RX Patent=US4980290;
RX PubMed=2822239;
RX PubMed=2835156;
RX PubMed=2841047;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 11
ST D5S818: 12,14
ST D7S820: 10,11
ST TH01: 9,9.3
ST TPOX: 8,10
ST vWA: 14
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SV-HUC-2
AC CVCL_G006
RX PubMed=2822239;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SV-HUC/ras-A
AC CVCL_IP92
SY SV-HUC/ras clone A; EJ/ras-A
RX PubMed=1316224;
RX PubMed=2164447;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3798 ! SV-HUC-1
SX Male
CA Transformed cell line
//
ID SV-HUC/ras-B
AC CVCL_IP93
SY SV-HUC/ras clone B
RX PubMed=2164447;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3798 ! SV-HUC-1
SX Male
CA Transformed cell line
//
ID SV-HUC/ras-C
AC CVCL_IP94
SY SV-HUC/ras clone C
RX PubMed=2164447;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3798 ! SV-HUC-1
SX Male
CA Transformed cell line
//
ID SV-HUC/ras-D
AC CVCL_IP95
SY SV-HUC/ras clone D
RX PubMed=2164447;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3798 ! SV-HUC-1
SX Male
CA Transformed cell line
//
ID SV-HUC/ras-E
AC CVCL_IP96
SY SV-HUC/ras clone E
RX PubMed=2164447;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3798 ! SV-HUC-1
SX Male
CA Transformed cell line
//
ID SV-HUC/ras-F
AC CVCL_IP97
SY SV-HUC/ras clone F
RX PubMed=2164447;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3798 ! SV-HUC-1
SX Male
CA Transformed cell line
//
ID SV-HUC/ras-G
AC CVCL_IP98
SY SV-HUC/ras clone G
RX PubMed=2164447;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3798 ! SV-HUC-1
SX Male
CA Transformed cell line
//
ID SV-JD
AC CVCL_H239
SY SVJD
RX PubMed=8212552;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Could be identical to SV6-1 Bam/HFK (CVCL_H240).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SV-Mm-11
AC CVCL_V317
RX PubMed=217958;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_V316 ! Mm-2K
SX Male
CA Transformed cell line
//
ID SV-Mm-12
AC CVCL_V318
RX PubMed=217958;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_V316 ! Mm-2K
SX Male
CA Transformed cell line
//
ID SV-Mm-12A
AC CVCL_V319
RX PubMed=217958;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_V318 ! SV-Mm-12
SX Male
CA Transformed cell line
//
ID SV-Mm-13
AC CVCL_V320
RX PubMed=217958;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_V316 ! Mm-2K
SX Male
CA Transformed cell line
//
ID SV-Mm-21
AC CVCL_V321
RX PubMed=217958;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_V316 ! Mm-2K
SX Male
CA Transformed cell line
//
ID SV-T2
AC CVCL_4554
SY BALB 3T3 SV-T2
DR CLO; CLO_0009181
DR CLDB; cl4423
DR CLDB; cl4424
DR CLDB; cl4425
DR ATCC; CCL-163.1
DR ChEMBL-Cells; CHEMBL3307978
DR ChEMBL-Targets; CHEMBL612564
DR ECACC; 90030801
DR IZSLER; BS CL 106
DR JCRB; JCRB9099
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0184 ! BALB/3T3 clone A31
CA Transformed cell line
//
ID SV-TGo
AC CVCL_T958
RX PubMed=212573;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SV/HF-5/39
AC CVCL_G293
SY SV/HF-5 Cl39
RX PubMed=2823105;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_G292 ! HS74
CA Transformed cell line
//
ID SV3T3B
AC CVCL_4311
DR CLO; CLO_0009166
DR CLDB; cl4427
DR ECACC; 85011409
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID SV40 MES 13
AC CVCL_5368
SY SV40-MES13; MES-13; MES 13; MES13
DR CLO; CLO_0009167
DR ATCC; CRL-1927
DR BCRC; 60366
DR GEO; GSE2557
RX PubMed=2835539;
RX PubMed=17178593;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MES-13
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID SV40 OFPAE
AC CVCL_6G13
SY SV40-transformed Ovine FetoPlacental Artery Endothelial cells
RX PubMed=17005940;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRNS-1].
OX NCBI_TaxID=9940; ! Ovis aries
CA Transformed cell line
//
ID SV40-tsA58 OMCD
AC CVCL_6B06
RX PubMed=8852699;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Miscellaneous: As no precise cell line name was given in the paper, we assigned the name based on the immortalization technique and the primary cell type name.
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SV40-tsA58 S1
AC CVCL_6B07
RX PubMed=8595391;
RX PubMed=8852699;
RX PubMed=9224657;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Miscellaneous: As no precise cell line name was given in the paper, we assigned the name based on the immortalization technique and the primary cell type name.
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SV40-tsA58 S3
AC CVCL_6B08
RX PubMed=8852699;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Miscellaneous: As no precise cell line name was given in the paper, we assigned the name based on the immortalization technique and the primary cell type name.
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SV40LT-SMC Clone HEP-SA
AC CVCL_6454
DR CLO; CLO_0009169
DR ATCC; CRL-2018
DR BCRC; 60523
RX PubMed=2154504;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID SV40T-DPC
AC CVCL_T950
SY SV40T-transformed Dermal Papilla Cells
RX PubMed=17560084;
CC Characteristics: SV40-transformed but with a finite life span.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID SV40T-hTERT-DPC
AC CVCL_T951
RX PubMed=21871174;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T950 ! SV40T-DPC
CA Telomerase immortalized cell line
//
ID SV6
AC CVCL_0E03
SY SPAML/SV6
DR ATCC; CRL-2427
RX PubMed=11485907;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-2427; true.
DI NCIt; C3888; Renal angiomyolipoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SV6-1 Bam/HFK
AC CVCL_H240
SY SV6-1 BAM/HFK; SV61 Bam/HFK
RX PubMed=2423124;
RX PubMed=2447927;
RX PubMed=6191883;
RX PubMed=6319304;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Could be identical to SV-JD (CVCL_H239).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID SV63
AC CVCL_F768
DR CLO; CLO_0009170
DR ATCC; HB-8766
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID SV68c-IS
AC CVCL_M084
SY SV68 c-IS
DR BTO; BTO:0003529
RX PubMed=11123759;
RX PubMed=17760834;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: ICR.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID SV7
AC CVCL_J654
SY SPAML/SV7
DR BTO; BTO:0004391
DR ATCC; CRL-2428
RX PubMed=11485907;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-2428; true.
DI NCIt; C3888; Renal angiomyolipoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SV7tert
AC CVCL_3602
SY SV7 tert
DR BTO; BTO:0004390
DR CLO; CLO_0009171
DR ATCC; CRL-2461
DR BioSample; SAMN03471581
RX PubMed=11485907;
RX PubMed=17592550;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3888; Renal angiomyolipoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_J654 ! SV7
SX Female
CA Telomerase immortalized cell line
//
ID SV7tert PDGF
AC CVCL_0F39
DR ATCC; CRL-4007
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-4007; true.
DI NCIt; C3888; Renal angiomyolipoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3602 ! SV7tert
SX Female
CA Telomerase immortalized cell line
//
ID SV7tert PDGFtu1
AC CVCL_C573
SY SV7tert PDGF tumor-1
DR ATCC; CRL-4008
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3888; Renal angiomyolipoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3602 ! SV7tert
SX Female
CA Telomerase immortalized cell line
//
ID SV7tert PDGFtu2
AC CVCL_0F40
SY SV7tert PDGF tumor-2
DR ATCC; CRL-4009
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-4009; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3888; Renal angiomyolipoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3602 ! SV7tert
SX Female
CA Telomerase immortalized cell line
//
ID SV80
AC CVCL_0541
SY SV-80; SV 80
DR MCCL; MCC:0000442
DR ATCC; CRL-7725
DR CLS; 300345/p623_SV-80
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-7725; true.
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9,13
ST D18S51: 15,20
ST D21S11: 28,30
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 10
ST D8S1179: 11,15
ST FGA: 21,27
ST Penta D: 9
ST Penta E: 11,12
ST TH01: 9
ST TPOX: 10,11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SVCT
AC CVCL_2718
DR CLO; CLO_0009172
DR ECACC; 94122105
DR Ximbio; 152701
RX PubMed=2423124;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SVCT-MI2
AC CVCL_2719
SY SVCT-M12
DR ECACC; 98031105
DR Ximbio; 152596
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2718 ! SVCT
SX Female
CA Transformed cell line
//
ID SVD-2
AC CVCL_6E59
RX PubMed=6190988;
CC Characteristics: Transfected with two copies of the genome of a human papillomavirus type 1 virus.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SVDC
AC CVCL_6C14
RX PubMed=15598888;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SVE3
AC CVCL_Y908
RX PubMed=2478401;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SVEC4-10
AC CVCL_4393
DR BTO; BTO:0002826
DR CLO; CLO_0009173
DR ATCC; CRL-2181
DR BCRC; 60220
RX PubMed=2153170;
RX PubMed=8496612;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID SVEC4-10EE2
AC CVCL_4394
DR CLO; CLO_0009174
DR ATCC; CRL-2167
RX PubMed=8496612;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4393 ! SVEC4-10
SX Male
CA Transformed cell line
//
ID SVEC4-10EHR1
AC CVCL_4395
DR CLO; CLO_0009175
DR ATCC; CRL-2161
RX PubMed=8496612;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4393 ! SVEC4-10
SX Male
CA Transformed cell line
//
ID SVG
AC CVCL_5G14
SY SV40 immortalized Glial cell
RX PubMed=2983332;
RX PubMed=8689028;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SVG p12
AC CVCL_3797
SY SVGp12; SVG(P12)
DR BTO; BTO:0005184
DR CLO; CLO_0009176
DR ATCC; CRL-8621
DR BCRC; 60371
DR BioSample; SAMN03471204
DR IZSLER; BS CL 200
RX Patent=US4707448;
RX PubMed=24760884;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Cell line contaminated with BK polyomavirus strain UT (PubMed: 24760884).
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,11,12
ST D13S317: 8,13,14
ST D16S539: 10,11,12
ST D5S818: 11,12,14
ST D7S820: 10,12,13
ST TH01: 6,7,9.3
ST TPOX: 8,10,11
ST vWA: 15,16,18,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5G14 ! SVG
SX Male
CA Transformed cell line
//
ID SVG-A
AC CVCL_5G13
DR GEO; GSM189708
DR GEO; GSM189709
DR GEO; GSM189710
DR GEO; GSM189714
DR GEO; GSM189715
DR GEO; GSM189716
RX PubMed=11517388;
RX PubMed=14517064;
RX PubMed=17555786;
RX PubMed=24760884;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Transcriptome analysis.
CC Caution: In contrast to SVG p12 (CVCL_3797), this cell line is not contaminated with BK polyomavirus (PubMed: 24760884).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5G14 ! SVG
CA Transformed cell line
//
ID SVG-TH
AC CVCL_5F78
RX PubMed=8689028;
CC Transfected with: HGNC; 11782; TH.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5G14 ! SVG
CA Transformed cell line
//
ID SVGR2
AC CVCL_IM78
DR GEO; GSM189711
DR GEO; GSM189712
DR GEO; GSM189713
DR GEO; GSM189717
DR GEO; GSM189718
DR GEO; GSM189719
RX PubMed=14517064;
RX PubMed=17555786;
CC Characteristics: Resistant to human polyomavirus JCV infection.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5G13 ! SVG-A
CA Transformed cell line
//
ID SVI
AC CVCL_5943
DR CLS; 400495/p8093_SVI
RX PubMed=15200416;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SVK-1
AC CVCL_D805
SY Stria Vascularis K-1
RX CelloPub=CLPUB00246;
RX PubMed=12382283;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SVK-2
AC CVCL_D806
SY Stria Vascularis K-2
RX CelloPub=CLPUB00246;
RX PubMed=12382283;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SVK14
AC CVCL_4Z59
SY SVK-14; SVK 14
RX PubMed=2423124;
RX PubMed=6180835;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID SVM84
AC CVCL_9127
RX PubMed=3013792;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_9126 ! DM87
SX Male
CA Transformed cell line
//
ID SVMC-a
AC CVCL_6C25
RX PubMed=16822814;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Conditionally immortalized cell line
//
ID SVMC-c
AC CVCL_6C26
RX PubMed=16822814;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Conditionally immortalized cell line
//
ID SVMC-E
AC CVCL_6C27
RX PubMed=16822814;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Conditionally immortalized cell line
//
ID SVNK-1
AC CVCL_6C28
SY SVNK 1
RX PubMed=16845125;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6C29 ! SVNK-2
OI CVCL_6C30 ! SVNK-3
OI CVCL_6C31 ! SVNK-4
OI CVCL_6C32 ! SVNK-6
OI CVCL_6C33 ! SVNK-8
OI CVCL_6C34 ! SVNK-9
OI CVCL_6C35 ! SVNK-10
SX Female
CA Conditionally immortalized cell line
//
ID SVNK-10
AC CVCL_6C35
SY SVNK 10
RX PubMed=16845125;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6C28 ! SVNK-1
OI CVCL_6C29 ! SVNK-2
OI CVCL_6C30 ! SVNK-3
OI CVCL_6C31 ! SVNK-4
OI CVCL_6C32 ! SVNK-6
OI CVCL_6C33 ! SVNK-8
OI CVCL_6C34 ! SVNK-9
SX Female
CA Conditionally immortalized cell line
//
ID SVNK-2
AC CVCL_6C29
SY SVNK 2
RX PubMed=16845125;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6C28 ! SVNK-1
OI CVCL_6C30 ! SVNK-3
OI CVCL_6C31 ! SVNK-4
OI CVCL_6C32 ! SVNK-6
OI CVCL_6C33 ! SVNK-8
OI CVCL_6C34 ! SVNK-9
OI CVCL_6C35 ! SVNK-10
SX Female
CA Conditionally immortalized cell line
//
ID SVNK-3
AC CVCL_6C30
SY SVNK 3
RX PubMed=16845125;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6C28 ! SVNK-1
OI CVCL_6C29 ! SVNK-2
OI CVCL_6C31 ! SVNK-4
OI CVCL_6C32 ! SVNK-6
OI CVCL_6C33 ! SVNK-8
OI CVCL_6C34 ! SVNK-9
OI CVCL_6C35 ! SVNK-10
SX Female
CA Conditionally immortalized cell line
//
ID SVNK-4
AC CVCL_6C31
SY SVNK 4
RX PubMed=16845125;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6C28 ! SVNK-1
OI CVCL_6C29 ! SVNK-2
OI CVCL_6C30 ! SVNK-3
OI CVCL_6C32 ! SVNK-6
OI CVCL_6C33 ! SVNK-8
OI CVCL_6C34 ! SVNK-9
OI CVCL_6C35 ! SVNK-10
SX Female
CA Conditionally immortalized cell line
//
ID SVNK-6
AC CVCL_6C32
SY SVNK 6
RX PubMed=16845125;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6C28 ! SVNK-1
OI CVCL_6C29 ! SVNK-2
OI CVCL_6C30 ! SVNK-3
OI CVCL_6C31 ! SVNK-4
OI CVCL_6C33 ! SVNK-8
OI CVCL_6C34 ! SVNK-9
OI CVCL_6C35 ! SVNK-10
SX Female
CA Conditionally immortalized cell line
//
ID SVNK-8
AC CVCL_6C33
SY SVNK 8
RX PubMed=16845125;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6C28 ! SVNK-1
OI CVCL_6C29 ! SVNK-2
OI CVCL_6C30 ! SVNK-3
OI CVCL_6C31 ! SVNK-4
OI CVCL_6C32 ! SVNK-6
OI CVCL_6C34 ! SVNK-9
OI CVCL_6C35 ! SVNK-10
SX Female
CA Conditionally immortalized cell line
//
ID SVNK-9
AC CVCL_6C34
SY SVNK 9
RX PubMed=16845125;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6C28 ! SVNK-1
OI CVCL_6C29 ! SVNK-2
OI CVCL_6C30 ! SVNK-3
OI CVCL_6C31 ! SVNK-4
OI CVCL_6C32 ! SVNK-6
OI CVCL_6C33 ! SVNK-8
OI CVCL_6C35 ! SVNK-10
SX Female
CA Conditionally immortalized cell line
//
ID SVOG-3e
AC CVCL_IN98
SY SVOG3e
DR BTO; BTO:0005892
RX PubMed=26408257;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SVOG-4m
AC CVCL_E241
SY SVOG-4M
RX PubMed=8832577;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E242 ! SVOG-4o
SX Female
CA Transformed cell line
//
ID SVOG-4o
AC CVCL_E242
SY SVOG-4O
RX PubMed=8832577;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E241 ! SVOG-4m
SX Female
CA Transformed cell line
//
ID SVpgC2a
AC CVCL_DG34
DR GEO; GSM298193
DR GEO; GSM190619
DR GEO; GSM190620
DR GEO; GSM966935
DR GEO; GSM966936
DR GEO; GSM966937
RX CelloPub=CLPUB00346;
RX PubMed=7586160;
RX PubMed=11377230;
RX PubMed=15651925;
RX PubMed=18186669;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID SVpgC2a-FOXM1B
AC CVCL_DH25
DR GEO; GSM298194
RX PubMed=19287496;
CC Transfected with: HGNC; 3818; FOXM1 (isoform FoxM1B).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DG34 ! SVpgC2a
SX Female
CA Transformed cell line
//
ID SVpgC2a-FOXM1B/SVFN1
AC CVCL_DH26
SY SVFN1
DR GEO; GSM298195
RX PubMed=19287496;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH25 ! SVpgC2a-FOXM1B
SX Female
CA Transformed cell line
//
ID SVpgC2a-FOXM1B/SVFN2
AC CVCL_DH27
SY SVFN2
DR GEO; GSM298196
RX PubMed=19287496;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH25 ! SVpgC2a-FOXM1B
SX Female
CA Transformed cell line
//
ID SVpgC2a-FOXM1B/SVFN3
AC CVCL_DH28
SY SVFN3
DR GEO; GSM298197
RX PubMed=19287496;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH25 ! SVpgC2a-FOXM1B
SX Female
CA Transformed cell line
//
ID SVpgC2a-FOXM1B/SVFN4
AC CVCL_DH29
SY SVFN4
DR GEO; GSM298198
RX PubMed=19287496;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH25 ! SVpgC2a-FOXM1B
SX Female
CA Transformed cell line
//
ID SVpgC2a-FOXM1B/SVFN5
AC CVCL_DH30
SY SVFN5
DR GEO; GSM298199
RX PubMed=19287496;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH25 ! SVpgC2a-FOXM1B
SX Female
CA Transformed cell line
//
ID SVpgC2a-FOXM1B/SVFN6
AC CVCL_DH31
SY SVFN6
DR GEO; GSM298200
RX PubMed=19287496;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH25 ! SVpgC2a-FOXM1B
SX Female
CA Transformed cell line
//
ID SVpgC2a-FOXM1B/SVFN7
AC CVCL_DH32
SY SVFN7
DR GEO; GSM298201
RX PubMed=19287496;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH25 ! SVpgC2a-FOXM1B
SX Female
CA Transformed cell line
//
ID SVpgC2a-FOXM1B/SVFN8
AC CVCL_DH33
SY SVFN8
DR GEO; GSM298202
RX PubMed=19287496;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: SNP array analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DH25 ! SVpgC2a-FOXM1B
SX Female
CA Transformed cell line
//
ID SVR
AC CVCL_6455
SY SVEN 1 ras
DR CLO; CLO_0009178
DR ATCC; CRL-2280
DR BCRC; 60219
DR ChEMBL-Cells; CHEMBL3307724
DR ChEMBL-Targets; CHEMBL614869
DR JCRB; NIHS0317
RX PubMed=9023347;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-127.html
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: JCRB; NIHS0317; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6502 ! MS1
CA Transformed cell line
//
ID SVR A221a
AC CVCL_6456
SY SVRA221a
DR CLO; CLO_0009179
DR ATCC; CRL-2386
DR JCRB; NIHS0316
RX PubMed=11106566;
CC Transfected with: MGI; MGI:1346866; Map2k1 (with A-222).
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: JCRB; NIHS0316; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6455 ! SVR
CA Transformed cell line
//
ID SVR bag4
AC CVCL_6457
SY SVRbag4
DR CLO; CLO_0009180
DR ATCC; CRL-2387
RX PubMed=11106566;
CC Transfected with: UniProtKB; P00722; E.coli lacZ.
CC Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6455 ! SVR
CA Transformed cell line
//
ID SVS24
AC CVCL_6A93
SY SVS 24
RX PubMed=9281449;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SVS30
AC CVCL_6A94
SY SVS 30
RX PubMed=9281449;
RX PubMed=11520047;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID SVts7-1
AC CVCL_W844
RX PubMed=1851674;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E939 ! TIG-3
SX Male
CA Transformed cell line
//
ID SVts8
AC CVCL_3173
SY SVts-8; TIG-3 SVts8
DR JCRB; JCRB0506.1
RX PubMed=1851674;
RX PubMed=9290701;
RX PubMed=10050041;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E939 ! TIG-3
SX Male
CA Transformed cell line
//
ID SW-8
AC CVCL_IR35
RX PubMed=3745952;
RX PubMed=6095297;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID SW-OH1
AC CVCL_S868
RX PubMed=12904596;
DI NCIt; C6586; Extrarenal rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW10
AC CVCL_6458
DR CLO; CLO_0009207
DR ATCC; CRL-2766
DR BCRC; 60550
RX PubMed=12210843;
CC Characteristics: At the permissive temperature (33 Celsius) proliferates. Does not proliferate at the restrictive temperature (37 Celsius).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID SW1007
AC CVCL_1E30
SY SW-1007; SW 1007
RX PubMed=327080;
RX PubMed=6244232;
RX PubMed=6935474;
RX PubMed=7459858;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW1016
AC CVCL_1E29
SY SW-1016; SW 1016
RX PubMed=327080;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW1045
AC CVCL_7164
SY SW-1045; SW 1045
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW1083
AC CVCL_L215
SY SW-1083; SW 1083
RX PubMed=1000501;
RX PubMed=1778766;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW1088
AC CVCL_1715
SY SW-1088; SW 1088
DR BTO; BTO:0000296
DR CLO; CLO_0009182
DR EFO; EFO_0002358
DR ATCC; HTB-12
DR BioSample; SAMN03471100
DR CCLE; SW1088_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3307573
DR ChEMBL-Targets; CHEMBL614243
DR Cosmic; 687584
DR Cosmic; 897442
DR Cosmic; 909745
DR Cosmic; 1036335
DR Cosmic; 2367550
DR Cosmic-CLP; 909745
DR GDSC; 909745
DR GEO; GSM887663
DR GEO; GSM888755
DR GEO; GSM1374914
DR GEO; GSM1670495
DR IGRhCellID; SW1088
DR IZSLER; BS TCL 129
RX PubMed=327080;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=11414198;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 9
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW1116
AC CVCL_0544
SY SW-1116; SW 1116
DR BTO; BTO:0001599
DR CLO; CLO_0009183
DR CLO; CLO_0009208
DR EFO; EFO_0002359
DR MCCL; MCC:0000445
DR CLDB; cl4429
DR ATCC; CCL-233
DR BCRC; 60307
DR BioSample; SAMN03473185
DR CCLE; SW1116_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308495
DR ChEMBL-Targets; CHEMBL614942
DR CLS; 300348/p594_SW-1116
DR Cosmic; 711271
DR Cosmic; 719678
DR Cosmic; 724847
DR Cosmic; 733171
DR Cosmic; 887241
DR Cosmic; 889526
DR Cosmic; 909746
DR Cosmic; 948834
DR Cosmic; 1122331
DR Cosmic; 1187320
DR Cosmic; 1223147
DR Cosmic; 1310939
DR Cosmic; 1312312
DR Cosmic; 1479569
DR Cosmic; 1609499
DR Cosmic; 1676732
DR Cosmic; 1805266
DR Cosmic; 1995649
DR Cosmic; 2267317
DR Cosmic; 2302012
DR Cosmic; 2433753
DR Cosmic-CLP; 909746
DR ECACC; 87071006
DR GDSC; 909746
DR GEO; GSM206546
DR GEO; GSM513920
DR GEO; GSM514307
DR GEO; GSM741267
DR GEO; GSM784013
DR GEO; GSM827441
DR GEO; GSM887664
DR GEO; GSM888756
DR GEO; GSM1346887
DR GEO; GSM1374915
DR GEO; GSM1374916
DR GEO; GSM1374917
DR GEO; GSM1448114
DR GEO; GSM1670496
DR IGRhCellID; SW1116
DR IZSLER; BS TCL 96
DR KCLB; 10233
DR NCBI_Iran; C481
RX PubMed=1000501;
RX PubMed=1778766;
RX PubMed=3349466;
RX PubMed=6935474;
RX PubMed=7104989;
RX PubMed=8422623;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=26537799;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SW116' in Cosmic 1122331 and Cosmic 1676732.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,14
ST D16S539: 9,12
ST D18S51: 13
ST D21S11: 28,29
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 12 (ATCC; CLS; Cosmic-CLP; KCLB; PubMed=25877200)
ST D7S820: 11,12 (ECACC)
ST D8S1179: 10,11
ST FGA: 21,22
ST Penta D: 11,13
ST Penta E: 10,12
ST TH01: 6 (ATCC; CLS; Cosmic-CLP; ECACC; PubMed=25877200)
ST TH01: 7 (KCLB)
ST TPOX: 8,11
ST vWA: 14,19
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW1222
AC CVCL_3886
SY SW-1222; SW 1222
DR BTO; BTO:0003105
DR Cosmic; 876714
DR Cosmic; 948833
DR Cosmic; 985653
DR Cosmic; 986017
DR Cosmic; 995398
DR Cosmic; 1043827
DR Cosmic; 1223148
DR Cosmic; 1312313
DR Cosmic; 1479605
DR Cosmic; 1482523
DR Cosmic; 1524330
DR Cosmic; 1803950
DR Cosmic; 2302013
DR ECACC; 12022910
DR GEO; GSM1346888
DR GEO; GSM1374918
DR GEO; GSM1448088
DR Ximbio; 152434
RX PubMed=1778766;
RX PubMed=6582512;
RX PubMed=10737795;
RX PubMed=20606684;
RX PubMed=24755471;
RX PubMed=25926053;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC Omics: Transcriptome analysis.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 9,13
ST D16S539: 9,10
ST D5S818: 9
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 10
ST vWA: 18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW1271
AC CVCL_1716
SY SW-1271; SW 1271
DR CLO; CLO_0009184
DR ATCC; CRL-2177
DR BioSample; SAMN03472877
DR CCLE; SW1271_LUNG
DR Cosmic; 701079
DR Cosmic; 929966
DR Cosmic; 932919
DR Cosmic; 1925844
DR Cosmic-CLP; 1299062
DR GDSC; 1299062
DR GEO; GSM169452
DR GEO; GSM887665
DR GEO; GSM888757
DR GEO; GSM986181
DR GEO; GSM1670497
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 13
ST D16S539: 11,12
ST D18S51: 14
ST D21S11: 29,31.2
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 13,16
ST FGA: 20
ST Penta D: 10,12
ST Penta E: 5,12
ST TH01: 7,8
ST TPOX: 8
ST vWA: 17,20
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW13
AC CVCL_0542
SY SW-13; SW 13; Scott and White No. 13
DR CLO; CLO_0009185
DR CLO; CLO_0009209
DR MCCL; MCC:0000444
DR CLDB; cl4435
DR CLDB; cl4436
DR ATCC; CCL-105
DR BCRC; 60483
DR BCRJ; 0300
DR BioSample; SAMN03472418
DR BioSample; SAMN03472692
DR CCRID; 3111C0001CCC000055
DR CCRID; 3131C0001000700054
DR ChEMBL-Cells; CHEMBL3308467
DR ChEMBL-Targets; CHEMBL1075587
DR CLS; 300349/p565_SW-13
DR Cosmic; 684683
DR Cosmic; 909744
DR Cosmic; 1024274
DR Cosmic; 1179077
DR Cosmic; 1622872
DR Cosmic; 2239456
DR Cosmic-CLP; 909744
DR ECACC; 87031801
DR GDSC; 909744
DR GEO; GSM827353
DR GEO; GSM1670498
DR IZSLER; BS TCL 62
DR JCRB; JCRB9069
DR KCB; KCB 200780YJ
DR KCLB; 10105
DR TOKU-E; 3228
RX CelloPub=CLPUB00337;
RX DOI=10.1007/978-1-4757-1647-4_2;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6244232;
RX PubMed=7459858;
RX PubMed=11414198;
RX PubMed=21924324;
RX PubMed=22266826;
RX PubMed=27397505;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=SW-13
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-332.html
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; ECACC; JCRB; KCLB
ST Amelogenin: X
ST CSF1PO: 11,12 (ATCC; Cosmic-CLP; KCLB)
ST CSF1PO: 12 (CLS; ECACC; JCRB)
ST D13S317: 9
ST D16S539: 12
ST D18S51: 17
ST D21S11: 31,32.2
ST D3S1358: 16
ST D5S818: 12 (ATCC; Cosmic-CLP; ECACC)
ST D5S818: 11,12 (CLS; JCRB; KCLB)
ST D7S820: 8,10
ST D8S1179: 10
ST FGA: 20
ST Penta D: 10,13
ST Penta E: 7,15
ST TH01: 7,8 (ATCC; CLS; Cosmic-CLP; ECACC; KCLB)
ST TH01: 7 (JCRB)
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW1318
AC CVCL_6G40
SY SW-1318; SW 1318
RX PubMed=6244232;
RX PubMed=7459858;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Derived from metastatic site: Brain.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW1353
AC CVCL_0543
SY SW-1353; SW 1353
DR BTO; BTO:0002003
DR CLO; CLO_0009186
DR CLO; CLO_0009210
DR EFO; EFO_0002360
DR MCCL; MCC:0000443
DR CLDB; cl4957
DR ATCC; HTB-94
DR BCRC; 60548
DR BCRJ; 0382
DR BioSample; SAMN03472765
DR CCLE; SW1353_BONE
DR CCRID; 3131C0001000700128
DR ChEMBL-Cells; CHEMBL3307462
DR ChEMBL-Targets; CHEMBL614944
DR CLS; 300440/p794_SW-1353
DR Cosmic; 923378
DR Cosmic; 1602475
DR Cosmic; 1992321
DR GEO; GSM887666
DR GEO; GSM888758
DR GEO; GSM1670499
DR GEO; GSM1676319
DR GEO; GSM1701652
DR ICLC; HTL99008
DR IGRhCellID; SW1353
DR IZSLER; BS TCL 213
DR NCBI_Iran; C571
DR TOKU-E; 3213
RX PubMed=15950496;
RX PubMed=19787792;
RX PubMed=22057234;
RX PubMed=22460905;
RX PubMed=26351324;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Characteristics: Heterozygous for the IDH2 p.Arg132Ser mutation.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,13
ST D16S539: 11,12
ST D18S51: 13,17
ST D21S11: 30,32.2
ST D3S1358: 15,18
ST D5S818: 10,11
ST D7S820: 9,11
ST D8S1179: 10,11
ST FGA: 22,23
ST Penta D: 10,11
ST Penta E: 12,14
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW1370
AC CVCL_6G41
SY SW-1370; SW 1370
RX PubMed=6244232;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW1398
AC CVCL_3885
SY SW-1398; SW 1398
DR BTO; BTO:0003746
RX PubMed=26537799;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Omics: Deep glycome analysis.
DI NCIt; C2955; Colorectal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW1417
AC CVCL_1717
SY SW-1417; SW 1417
DR BTO; BTO:0001536
DR CLO; CLO_0009187
DR CLO; CLO_0009211
DR EFO; EFO_0002361
DR CLDB; cl4430
DR ATCC; CCL-238
DR BioSample; SAMN03471478
DR BioSample; SAMN03471575
DR CCLE; SW1417_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308129
DR ChEMBL-Targets; CHEMBL1075588
DR Cosmic; 685869
DR Cosmic; 909747
DR Cosmic; 948838
DR Cosmic; 986018
DR Cosmic; 995413
DR Cosmic; 1043826
DR Cosmic; 1090352
DR Cosmic; 1187321
DR Cosmic; 1310940
DR Cosmic; 1312314
DR Cosmic; 1466825
DR Cosmic; 1479614
DR Cosmic; 1609491
DR Cosmic; 1708405
DR Cosmic; 1995650
DR Cosmic; 2302014
DR Cosmic-CLP; 909747
DR ECACC; 90102543
DR GDSC; 909747
DR GEO; GSM206547
DR GEO; GSM513921
DR GEO; GSM514308
DR GEO; GSM741248
DR GEO; GSM827354
DR GEO; GSM887667
DR GEO; GSM888759
DR GEO; GSM1346857
DR GEO; GSM1374919
DR GEO; GSM1374920
DR GEO; GSM1448089
DR GEO; GSM1670500
DR ICLC; HTL00005
DR IGRhCellID; SW1417
RX PubMed=1778766;
RX PubMed=6935474;
RX PubMed=7104989;
RX PubMed=7459858;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/SW1417.html
WW http://tcpaportal.org/mclp/
CC Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: 68 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ICLC; HTL00005; true.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,12 (ATCC; Cosmic-CLP)
ST D13S317: 12 (PubMed=25877200)
ST D16S539: 11,12
ST D18S51: 15
ST D21S11: 29,32.2,33.2
ST D3S1358: 15,16
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 8
ST FGA: 23
ST Penta D: 9,12
ST Penta E: 8
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW1463
AC CVCL_1718
SY SW-1463; SW 1463
DR CLO; CLO_0009188
DR CLO; CLO_0009212
DR EFO; EFO_0002362
DR CLDB; cl4431
DR ATCC; CCL-234
DR BCRC; 60521
DR BioSample; SAMN03471489
DR CCLE; SW1463_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308788
DR ChEMBL-Targets; CHEMBL1075589
DR Cosmic; 724851
DR Cosmic; 909748
DR Cosmic; 983735
DR Cosmic; 1071894
DR Cosmic; 1176595
DR Cosmic; 1310937
DR Cosmic; 1708416
DR Cosmic; 1995651
DR Cosmic; 2302015
DR Cosmic-CLP; 909748
DR ECACC; 90112713
DR GDSC; 909748
DR GEO; GSM206548
DR GEO; GSM513922
DR GEO; GSM514309
DR GEO; GSM827417
DR GEO; GSM887668
DR GEO; GSM888760
DR GEO; GSM1346858
DR GEO; GSM1448113
DR GEO; GSM1670501
DR IGRhCellID; SW1463
DR IZSLER; BS TCL 220
RX PubMed=7104989;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=26537799;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,13
ST D16S539: 11
ST D18S51: 18
ST D21S11: 30,31.2
ST D3S1358: 16,17
ST D5S818: 13,14
ST D7S820: 9
ST D8S1179: 11,15
ST FGA: 23,28
ST Penta D: 9,12
ST Penta E: 17
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW156
AC CVCL_1719
SY SW-156; SW 156
DR CLO; CLO_0009189
DR ATCC; CRL-2175
DR BioSample; SAMN03472558
DR Cosmic; 687943
DR Cosmic; 1995652
DR Cosmic-CLP; 1240220
DR GDSC; 1240220
DR GEO; GSM374475
DR GEO; GSM827270
DR GEO; GSM1670502
RX DOI=10.1007/978-1-4757-1647-4_2;
RX PubMed=833871;
RX PubMed=6244232;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 10,12
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW1573
AC CVCL_1720
SY SW-1573; SW 1573
DR BTO; BTO:0003016
DR CLO; CLO_0009190
DR EFO; EFO_0002363
DR ATCC; CRL-2170
DR BioSample; SAMN03473239
DR CCLE; SW1573_LUNG
DR ChEMBL-Cells; CHEMBL3307980
DR ChEMBL-Targets; CHEMBL612570
DR Cosmic; 724878
DR Cosmic; 1017831
DR Cosmic; 1802305
DR Cosmic; 2060538
DR Cosmic-CLP; 724878
DR GDSC; 724878
DR GEO; GSM206549
DR GEO; GSM385526
DR GEO; GSM385537
DR GEO; GSM827193
DR GEO; GSM887669
DR GEO; GSM888761
DR GEO; GSM1670503
DR IGRhCellID; SW1573
RX PubMed=6935474;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=4862
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 12,14
ST D18S51: 16
ST D21S11: 29
ST D3S1358: 14,18
ST D5S818: 12,13
ST D7S820: 9,11
ST D8S1179: 11
ST FGA: 21
ST Penta D: 9
ST Penta E: 5,13
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 20
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW161
AC CVCL_1E52
SY SW-161; SW 161
RX DOI=10.1007/978-1-4757-1647-4_2;
RX PubMed=833871;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C2923; Bronchioloalveolar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW1710
AC CVCL_1721
SY SW-1710; SW 1710
DR CLO; CLO_0009213
DR BioSample; SAMN03473594
DR CCLE; SW1710_URINARY_TRACT
DR ChEMBL-Cells; CHEMBL3308804
DR ChEMBL-Targets; CHEMBL1075590
DR Cosmic; 715750
DR Cosmic; 760483
DR Cosmic; 845572
DR Cosmic; 909749
DR Cosmic; 1016890
DR Cosmic; 1046685
DR Cosmic; 1285129
DR Cosmic; 1285989
DR Cosmic; 2037957
DR Cosmic; 2050463
DR Cosmic; 2057458
DR Cosmic; 2444251
DR Cosmic-CLP; 909749
DR DSMZ; ACC-426
DR GDSC; 909749
DR GEO; GSM763023
DR GEO; GSM827181
DR GEO; GSM887670
DR GEO; GSM888762
DR GEO; GSM1374921
DR GEO; GSM1574554
DR GEO; GSM1670504
RX PubMed=6744315;
RX PubMed=6935474;
RX PubMed=16885334;
RX PubMed=22460905;
RX PubMed=24018021;
RX PubMed=24367658;
RX PubMed=25997541;
RX PubMed=26621286;
RX PubMed=27397505;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: ~25-32 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 8,11
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 7,10 (Cosmic-CLP)
ST TH01: 7,8,9.3 (DSMZ)
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW1736
AC CVCL_3883
SY SW-1736; SW 1736
DR BTO; BTO:0001611
DR ChEMBL-Cells; CHEMBL3307699
DR ChEMBL-Targets; CHEMBL614773
DR CLS; 300453/p463_SW-1736
DR Cosmic; 886549
DR Cosmic; 1068627
DR Cosmic; 1239961
DR Cosmic; 1280048
DR Cosmic; 1507375
DR Cosmic; 1533551
DR Cosmic; 1536128
DR Cosmic; 1889006
DR Cosmic; 2050366
DR Cosmic; 2054081
DR Cosmic; 2319853
RX PubMed=17465858;
RX PubMed=18713817;
RX PubMed=21868764;
RX PubMed=23833040;
CC From: Scott and White Clinic; Temple; Texas; USA.
ST Source(s): CLS; PubMed=18713817; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D18S51: 14
ST D21S11: 29,31
ST D3S1358: 16,17
ST D5S818: 12,13
ST D7S820: 8,11
ST D8S1179: 13 (CLS)
ST D8S1179: 13,14 (PubMed=18713817)
ST FGA: 22
ST Penta D: 12
ST Penta E: 11,17
ST TH01: 6
ST TPOX: 11
ST vWA: 16,19
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW1738
AC CVCL_A683
SY SW-1738; SW 1738
RX PubMed=6744315;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW1783
AC CVCL_1722
SY SW-1783; SW 1783
DR CLO; CLO_0009191
DR EFO; EFO_0002364
DR ATCC; HTB-13
DR BioSample; SAMN03472711
DR CCLE; SW1783_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3308369
DR ChEMBL-Targets; CHEMBL1075591
DR Cosmic; 687585
DR Cosmic; 897443
DR Cosmic; 909750
DR Cosmic; 2367551
DR Cosmic; 2516039
DR Cosmic-CLP; 909750
DR GDSC; 909750
DR GEO; GSM887671
DR GEO; GSM888763
DR GEO; GSM1374922
DR GEO; GSM1670505
DR IGRhCellID; SW1783
DR IZSLER; BS TCL 193
RX PubMed=11414198;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: 55 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 9,11
ST D16S539: 12
ST D5S818: 12,13 (ATCC)
ST D5S818: 12 (Cosmic-CLP)
ST D7S820: 9,13
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW1990
AC CVCL_1723
SY SW-1990; SW 1990
DR BTO; BTO:0003491
DR CLO; CLO_0009192
DR CLO; CLO_0009194
DR EFO; EFO_0002365
DR CLDB; cl4438
DR ATCC; CRL-2172
DR BioSample; SAMN03472179
DR CCLE; SW1990_PANCREAS
DR CGH-DB; 184-1
DR CGH-DB; 9275-4
DR ChEMBL-Cells; CHEMBL3308789
DR ChEMBL-Targets; CHEMBL1075592
DR Cosmic; 724871
DR Cosmic; 910907
DR Cosmic; 913312
DR Cosmic; 1609543
DR Cosmic; 2434093
DR Cosmic-CLP; 910907
DR GDSC; 910907
DR GEO; GSM206550
DR GEO; GSM621893
DR GEO; GSM784708
DR GEO; GSM887672
DR GEO; GSM888764
DR GEO; GSM1024415
DR GEO; GSM1670506
DR IGRhCellID; SW1990
DR KCB; KCB 2012113YJ
DR PRIDE; PXD003198
DR TOKU-E; 3217
RX PubMed=6871872;
RX PubMed=15126341;
RX PubMed=15688027;
RX PubMed=18380791;
RX PubMed=22460905;
RX PubMed=25167228;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27259358;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SW1990
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: 72 hours (PubMed=25984343); 35.8 +- 4.4 hours (PubMed=27067801).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,12
ST D16S539: 13
ST D18S51: 13
ST D21S11: 31
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 9,10
ST D8S1179: 11,14
ST FGA: 26
ST Penta D: 11
ST Penta E: 5,7
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW2
AC CVCL_R777
SY SW-2
DR BTO; BTO:0005501
CC From: Bernal S.D.; Dana-Farber Cancer Institute; Boston; USA.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW210.5
AC CVCL_S185
RX PubMed=11414198;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW213
AC CVCL_1E93
SY SW-213; SW 213
RX DOI=10.1007/978-1-4757-1647-4_2;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW267
AC CVCL_1E53
SY SW-267; SW 267
RX DOI=10.1007/978-1-4757-1647-4_2;
RX PubMed=833871;
RX PubMed=6935474;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C5328; Extra-adrenal retroperitoneal paraganglioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW403
AC CVCL_0545
SY SW-403; SW 403
DR BTO; BTO:0000033
DR CLO; CLO_0009193
DR CLO; CLO_0009214
DR CLO; CLO_0009215
DR EFO; EFO_0002366
DR MCCL; MCC:0000446
DR CLDB; cl4432
DR ATCC; CCL-230
DR BCRC; 60258
DR BioSample; SAMN01821601
DR BioSample; SAMN01821667
DR BioSample; SAMN03473184
DR CCLE; SW403_LARGE_INTESTINE
DR CLS; 300350/p477_SW-403
DR Cosmic; 724848
DR Cosmic; 738937
DR Cosmic; 876718
DR Cosmic; 910908
DR Cosmic; 934566
DR Cosmic; 948128
DR Cosmic; 948831
DR Cosmic; 983731
DR Cosmic; 986019
DR Cosmic; 995394
DR Cosmic; 1071893
DR Cosmic; 1176594
DR Cosmic; 1184097
DR Cosmic; 1187322
DR Cosmic; 1310938
DR Cosmic; 1312315
DR Cosmic; 1479587
DR Cosmic; 1609502
DR Cosmic; 1676749
DR Cosmic; 1708408
DR Cosmic; 1805267
DR Cosmic; 2302016
DR Cosmic-CLP; 910908
DR DSMZ; ACC-294
DR ECACC; 87071008
DR GDSC; 910908
DR GEO; GSM206551
DR GEO; GSM513923
DR GEO; GSM514310
DR GEO; GSM741263
DR GEO; GSM887673
DR GEO; GSM888765
DR GEO; GSM1346889
DR GEO; GSM1374923
DR GEO; GSM1374924
DR GEO; GSM1448194
DR IGRhCellID; SW403
DR KCLB; 10230
RX PubMed=327080;
RX PubMed=1000501;
RX PubMed=6582512;
RX PubMed=7104989;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/SW403.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: ~40-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; DSMZ; ECACC; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 13
ST D16S539: 10,12
ST D18S51: 17
ST D21S11: 28,29
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 11 (CLS)
ST D8S1179: 11,14 (PubMed=25877200)
ST FGA: 19
ST Penta D: 9
ST Penta E: 5
ST TH01: 6
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW409
AC CVCL_1E94
SY SW-409; SW 409
RX DOI=10.1007/978-1-4757-1647-4_2;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW419
AC CVCL_1E95
SY SW-419; SW 419
RX DOI=10.1007/978-1-4757-1647-4_2;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Derived from metastatic site: Peritoneum.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW451
AC CVCL_1E55
SY SW-451; SW 451
RX PubMed=833871;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW47
AC CVCL_1E54
SY SW-47; SW 47
RX DOI=10.1007/978-1-4757-1647-4_2;
RX PubMed=833871;
RX PubMed=6244232;
RX PubMed=6935474;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Derived from metastatic site: Liver.
DI NCIt; C9325; Adrenal cortex carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW48
AC CVCL_1724
SY SW-48; SW 48
DR BTO; BTO:0001535
DR CLO; CLO_0009216
DR EFO; EFO_0002367
DR CLDB; cl4971
DR ATCC; CCL-231
DR BCRC; 60311
DR BioSample; SAMN03470827
DR BioSample; SAMN03471477
DR CCLE; SW48_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3307292
DR ChEMBL-Targets; CHEMBL614055
DR Cosmic; 687544
DR Cosmic; 711258
DR Cosmic; 870450
DR Cosmic; 873705
DR Cosmic; 876645
DR Cosmic; 876707
DR Cosmic; 887225
DR Cosmic; 889527
DR Cosmic; 909751
DR Cosmic; 948122
DR Cosmic; 948855
DR Cosmic; 986000
DR Cosmic; 995399
DR Cosmic; 1043828
DR Cosmic; 1057753
DR Cosmic; 1122330
DR Cosmic; 1132563
DR Cosmic; 1132688
DR Cosmic; 1175846
DR Cosmic; 1184089
DR Cosmic; 1184332
DR Cosmic; 1374624
DR Cosmic; 1466821
DR Cosmic; 1479633
DR Cosmic; 1552177
DR Cosmic; 1571771
DR Cosmic; 1609488
DR Cosmic; 1676725
DR Cosmic; 1708409
DR Cosmic; 1805268
DR Cosmic; 1995653
DR Cosmic; 2036657
DR Cosmic; 2052594
DR Cosmic; 2302017
DR Cosmic-CLP; 909751
DR ECACC; 89012702
DR GDSC; 909751
DR GEO; GSM513924
DR GEO; GSM514311
DR GEO; GSM741252
DR GEO; GSM827355
DR GEO; GSM844713
DR GEO; GSM887675
DR GEO; GSM888767
DR GEO; GSM1346890
DR GEO; GSM1374925
DR GEO; GSM1374926
DR GEO; GSM1374927
DR GEO; GSM1448165
DR GEO; GSM1670507
DR ICLC; HTL99020
DR IGRhCellID; SW48
DR NCBI_Iran; C480
DR SKY/M-FISH/CGH; 2838
RX CelloPub=CLPUB00337;
RX DOI=10.1007/978-1-4757-1647-4_2;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1000501;
RX PubMed=6652615;
RX PubMed=7104989;
RX PubMed=7459858;
RX PubMed=8422623;
RX PubMed=9000572;
RX PubMed=9515795;
RX PubMed=10612807;
RX PubMed=10737795;
RX PubMed=11314036;
RX PubMed=11526487;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=26537799;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=373
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: 33 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-high) (PubMed=9000572; ubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 13
ST D21S11: 28,31
ST D3S1358: 13,14,15
ST D5S818: 10,14
ST D7S820: 9,10
ST D8S1179: 13,14,15
ST FGA: 20
ST Penta D: 10
ST Penta E: 12,13
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 18,20,21 (ATCC)
ST vWA: 18,20 (Cosmic-CLP; ECACC; PubMed=25877200)
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW48 TP53(+/-)
AC CVCL_HE26
SY TP53 (+/-) SW48
RX PubMed=19225112;
WW https://www.horizondiscovery.com/human-tp53-sw48-cell-line-hd-r06-001
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 11998; TP53.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1724 ! SW48
SX Female
CA Cancer cell line
//
ID SW48 TP53(-/-)
AC CVCL_HE27
SY TP53 (-/-) SW48
RX PubMed=19225112;
WW https://www.horizondiscovery.com/human-tp53-sw48-cell-line-hd-103-004
CC Knockout cell: Method=Homologous recombination; HGNC; 11998; TP53.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1724 ! SW48
SX Female
CA Cancer cell line
//
ID SW480
AC CVCL_0546
SY SW-480; SW 480; SW480E
DR BTO; BTO:0000038
DR CLO; CLO_0009195
DR CLO; CLO_0009217
DR CLO; CLO_0009218
DR EFO; EFO_0002083
DR MCCL; MCC:0000447
DR CLDB; cl4440
DR CLDB; cl4441
DR CLDB; cl4966
DR ATCC; CCL-228
DR BCRC; 60249
DR BioSample; SAMN01821602
DR BioSample; SAMN03481110
DR CCLE; SW480_LARGE_INTESTINE
DR CCRID; 3111C0001CCC000166
DR CCRID; 3131C0001000700086
DR CCRID; 3142C0001000000064
DR ChEMBL-Cells; CHEMBL3307758
DR ChEMBL-Cells; CHEMBL3308067
DR ChEMBL-Targets; CHEMBL612544
DR ChEMBL-Targets; CHEMBL613840
DR CLS; 300302/p716_SW-480
DR Cosmic; 709847
DR Cosmic; 711272
DR Cosmic; 716169
DR Cosmic; 720332
DR Cosmic; 875293
DR Cosmic; 876719
DR Cosmic; 887240
DR Cosmic; 889536
DR Cosmic; 902791
DR Cosmic; 905006
DR Cosmic; 913892
DR Cosmic; 948827
DR Cosmic; 983732
DR Cosmic; 985652
DR Cosmic; 990302
DR Cosmic; 995393
DR Cosmic; 1043829
DR Cosmic; 1057764
DR Cosmic; 1066212
DR Cosmic; 1071888
DR Cosmic; 1122332
DR Cosmic; 1132573
DR Cosmic; 1132693
DR Cosmic; 1154645
DR Cosmic; 1176589
DR Cosmic; 1184095
DR Cosmic; 1184328
DR Cosmic; 1187323
DR Cosmic; 1223149
DR Cosmic; 1310935
DR Cosmic; 1332007
DR Cosmic; 1374642
DR Cosmic; 1466822
DR Cosmic; 1479588
DR Cosmic; 1482524
DR Cosmic; 1486130
DR Cosmic; 1524329
DR Cosmic; 1552183
DR Cosmic; 1571768
DR Cosmic; 1609479
DR Cosmic; 1676750
DR Cosmic; 1708398
DR Cosmic; 1803951
DR Cosmic; 2036653
DR Cosmic; 2145577
DR Cosmic; 2156941
DR Cosmic; 2267318
DR Cosmic; 2301547
DR Cosmic; 2302018
DR Cosmic; 2433752
DR DSMZ; ACC-313
DR ECACC; 87092801
DR ENCODE; ENCBS211HGL
DR ENCODE; ENCBS421AQW
DR GEO; GSM206552
DR GEO; GSM513930
DR GEO; GSM514312
DR GEO; GSM741258
DR GEO; GSM784022
DR GEO; GSM861349
DR GEO; GSM861350
DR GEO; GSM861351
DR GEO; GSM861352
DR GEO; GSM887674
DR GEO; GSM888766
DR GEO; GSM1346891
DR GEO; GSM1374928
DR GEO; GSM1374929
DR GEO; GSM1374930
DR GEO; GSM1448166
DR GEO; GSM1670508
DR ICLC; HTL99017
DR IGRhCellID; SW480
DR KCB; KCB 200848YJ
DR KCLB; 10228
DR NCBI_Iran; C506
DR PRIDE; PXD000089
DR PRIDE; PXD000230
DR PRIDE; PXD002793
DR PRIDE; PXD003708
DR SKY/M-FISH/CGH; 2839
DR SKY/M-FISH/CGH; 3982
DR TOKU-E; 3233
DR Wikidata; Q28472974
RX PubMed=288927;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1000501;
RX PubMed=1389533;
RX PubMed=1778766;
RX PubMed=3349466;
RX PubMed=6582512;
RX PubMed=7104989;
RX PubMed=7459858;
RX PubMed=8422623;
RX PubMed=8895552;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=9290701;
RX PubMed=10612807;
RX PubMed=10674020;
RX PubMed=10737795;
RX PubMed=10773689;
RX PubMed=11226274;
RX PubMed=11414198;
RX PubMed=11526487;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=26537799;
RX PubMed=27987026;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/SW480.html
WW http://www.addexbio.com/productdetail?pid=43
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-54.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: 24 hours (PubMed=25984343); ~25-30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=10674020; PubMed=24042735; PubMed=25926053).
CC Omics: Deep glycome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'WE480' or 'WE-480' in PubMed=12761194.
CC Misspelling: 'SW80' in ChEMBL CHEMBL613840 and CHEMBL3308067.
ST Source(s): AddexBio; ATCC; CLS; DSMZ; ECACC; KCLB; PubMed=11416159; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 12
ST D16S539: 13
ST D18S51: 13
ST D21S11: 30,30.2
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 8
ST D8S1179: 13
ST FGA: 24
ST Penta D: 9,15
ST Penta E: 10
ST TH01: 8
ST TPOX: 11
ST vWA: 16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0547 ! SW620
SX Male
CA Cancer cell line
//
ID SW480/5FUR
AC CVCL_AU16
WW https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW480/BEVA
AC CVCL_AU17
WW https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx
CC Selected for resistance to: Bevacizumab (Avastin).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW480/CMV-Luc
AC CVCL_4Y13
SY SW-480/CMV-Luc
DR JCRB; NIHS0738
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW480/nkR
AC CVCL_AT66
RX Patent=US7989001;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW480/nkS
AC CVCL_AT65
RX Patent=US7989001;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW480/OXR
AC CVCL_AU18
WW https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW480E
AC CVCL_AT67
SY SW480 E8
DR KCLB; 60067
RX Patent=US7989001;
RX PubMed=1458472;
ST Source(s): KCLB
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 12
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 8
ST FGA: 24
ST TH01: 8
ST TPOX: 11
ST vWA: 16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW480R
AC CVCL_AT68
SY SW480 R2
RX Patent=US7989001;
RX PubMed=1458472;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW489
AC CVCL_1E89
SY SW-489; SW 489
RX PubMed=833871;
RX PubMed=994214;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: 26 hours, at 10th passage (PubMed=994214).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW527
AC CVCL_3799
SY SW-527; SW 527
DR CLO; CLO_0009219
DR EFO; EFO_0005462
DR ATCC; CRL-7940
DR BioSample; SAMN03151930
DR BioSample; SAMN03481115
DR Cosmic; 1047713
DR LINCS; 50046
RX PubMed=288927;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=20143388;
RX PubMed=25485619;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SW527
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SW480 derivative (PubMed=288927, PubMed=20143388).
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): ATCC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 12
ST D16S539: 9,13
ST D18S51: 13
ST D21S11: 30,30.2
ST D3S1358: 15,16
ST D5S818: 13
ST D7S820: 8
ST D8S1179: 13
ST FGA: 24
ST Penta D: 9,15
ST Penta E: 10
ST TH01: 8
ST TPOX: 11
ST vWA: 16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW534
AC CVCL_1E56
SY SW-534; SW 534
RX PubMed=833871;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C4044; Laryngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW579
AC CVCL_3603
SY SW-579; SW 579
DR CLO; CLO_0009220
DR ATCC; HTB-107
DR BCRC; 60412
DR CCLE; SW579_THYROID
DR CCRID; 3111C0001CCC000264
DR CCRID; 3131C0001000700125
DR CLS; 300346/p467_SW-579
DR Cosmic; 1005454
DR Cosmic; 1006467
DR Cosmic; 1017791
DR Cosmic; 1041672
DR Cosmic; 1094773
DR Cosmic; 1339924
DR GEO; GSM887676
DR GEO; GSM888768
DR GEO; GSM1374931
DR GEO; GSM1374932
DR IGRhCellID; SW579
DR IZSLER; BS TCL 121
DR KCB; KCB 201304YJ
RX DOI=10.1016/B978-0-12-333530-2.50007-1;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 13
ST D16S539: 11
ST D18S51: 15,17,18
ST D21S11: 29,31
ST D3S1358: 15,18
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 11,13
ST FGA: 21,24
ST Penta D: 9,12
ST Penta E: 11,12
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 14,18
DI NCIt; C46008; Thyroid gland squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW594
AC CVCL_1E57
SY SW-594; SW 594
RX PubMed=833871;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW598
AC CVCL_F649
SY SW-598; SW 598
DR ATCC; CRL-2176
DR BioSample; SAMN03151931
RX PubMed=288927;
RX PubMed=833871;
RX PubMed=20143388;
WW http://www.atcc.org/support/faqs/9e860/SW%20598%20SW598%20SW598%20ATCC%20CRL2176-1059.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927, PubMed=20143388).
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Discontinued: ATCC; CRL-2176; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 12
ST D16S539: 13
ST D5S818: 13
ST D7S820: 8
ST TH01: 8
ST TPOX: 11
ST vWA: 16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW608
AC CVCL_F653
SY SW-608; SW 608
DR BioSample; SAMN03151932
RX PubMed=288927;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927, PubMed=20143388).
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW613
AC CVCL_F650
SY SW-613; SW 613
DR ATCC; CRL-2146
DR BioSample; SAMN03151933
DR ChEMBL-Cells; CHEMBL3307463
DR ChEMBL-Targets; CHEMBL614945
RX PubMed=288927;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927, PubMed=20143388).
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Discontinued: ATCC; CRL-2146; true.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW620
AC CVCL_0547
SY SW-620; SW 620; SW.620
DR BTO; BTO:0000675
DR CLO; CLO_0009196
DR CLO; CLO_0009221
DR EFO; EFO_0002368
DR MCCL; MCC:0000448
DR CLDB; cl4443
DR CLDB; cl4444
DR CLDB; cl4969
DR ATCC; CCL-227
DR BCRC; 60343
DR BioSample; SAMN03481108
DR CCLE; SW620_LARGE_INTESTINE
DR CCRID; 3111C0001CCC000207
DR CCRID; 3131C0001000700101
DR CCRID; 3142C0001000000118
DR ChEMBL-Cells; CHEMBL3307944
DR ChEMBL-Targets; CHEMBL612262
DR CLS; 300466/p859_SW-620
DR Cosmic; 719676
DR Cosmic; 724849
DR Cosmic; 873706
DR Cosmic; 875294
DR Cosmic; 875900
DR Cosmic; 876720
DR Cosmic; 887243
DR Cosmic; 889525
DR Cosmic; 897460
DR Cosmic; 905962
DR Cosmic; 934561
DR Cosmic; 948828
DR Cosmic; 974248
DR Cosmic; 983733
DR Cosmic; 986020
DR Cosmic; 990304
DR Cosmic; 1071889
DR Cosmic; 1092640
DR Cosmic; 1122333
DR Cosmic; 1154646
DR Cosmic; 1175845
DR Cosmic; 1176590
DR Cosmic; 1183768
DR Cosmic; 1184083
DR Cosmic; 1187324
DR Cosmic; 1219446
DR Cosmic; 1223150
DR Cosmic; 1305357
DR Cosmic; 1310936
DR Cosmic; 1312341
DR Cosmic; 1466823
DR Cosmic; 1479589
DR Cosmic; 1524325
DR Cosmic; 1552181
DR Cosmic; 1609505
DR Cosmic; 1676751
DR Cosmic; 1708397
DR Cosmic; 1995654
DR Cosmic; 1998483
DR Cosmic; 2156943
DR Cosmic; 2302019
DR Cosmic-CLP; 905962
DR ECACC; 87051203
DR GDSC; 905962
DR GEO; GSM50192
DR GEO; GSM50256
DR GEO; GSM206553
DR GEO; GSM513819
DR GEO; GSM513867
DR GEO; GSM514313
DR GEO; GSM514314
DR GEO; GSM741270
DR GEO; GSM750800
DR GEO; GSM784023
DR GEO; GSM799335
DR GEO; GSM799398
DR GEO; GSM847163
DR GEO; GSM887677
DR GEO; GSM888769
DR GEO; GSM1153405
DR GEO; GSM1181305
DR GEO; GSM1181343
DR GEO; GSM1346892
DR GEO; GSM1374933
DR GEO; GSM1374934
DR GEO; GSM1374935
DR GEO; GSM1448212
DR ICLC; HTL99015
DR IGRhCellID; SW620
DR LINCS; 50047
DR KCB; KCB 201198YJ
DR KCLB; 10227
DR KCLB; 60068
DR PRIDE; PXD000089
DR PRIDE; PXD003708
DR PRIDE; PXD004079
DR SKY/M-FISH/CGH; 2806
DR SKY/M-FISH/CGH; 5075
DR Wikidata; Q28519412
RX PubMed=288927;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1000501;
RX PubMed=2041050;
RX PubMed=6582512;
RX PubMed=9290701;
RX PubMed=10773689;
RX PubMed=11226274;
RX PubMed=11414198;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=26537799;
RX PubMed=27397505;
RX PubMed=27470641;
RX PubMed=27807467;
RX PubMed=27987026;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=18
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/SW620.html
WW http://www.addexbio.com/productdetail?pid=68
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-333.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: 20.4 hours (DTP).
CC Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=11416159; PubMed=19372543; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 12
ST D16S539: 9,13
ST D18S51: 13
ST D19S433: 13
ST D21S11: 30,30.2
ST D2S1338: 17,24
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 8,9
ST D8S1179: 13
ST FGA: 24
ST Penta D: 9,15
ST Penta E: 10
ST TH01: 8
ST TPOX: 11
ST vWA: 16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW620-Luc
AC CVCL_J268
DR JCRB; JCRB1399
DR JCRB; NIHS0648
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0648; true.
CC Derived from metastatic site: Lymph node.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 12
ST D16S539: 9
ST D5S818: 13
ST D7S820: 8,9
ST TH01: 8
ST TPOX: 11
ST vWA: 16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0547 ! SW620
SX Male
CA Cancer cell line
//
ID SW620-OX
AC CVCL_4V76
RX PubMed=24761924;
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
CC Derived from metastatic site: Lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0547 ! SW620
SX Male
CA Cancer cell line
//
ID SW620/L-OHP
AC CVCL_4V77
RX PubMed=20591218;
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
CC Derived from metastatic site: Lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0547 ! SW620
SX Male
CA Cancer cell line
//
ID SW626
AC CVCL_1725
SY SW-626; SW 626
DR BTO; BTO:0001881
DR CLO; CLO_0009197
DR CLO; CLO_0009222
DR CLDB; cl4446
DR ATCC; HTB-78
DR BioSample; SAMN03472756
DR BioSample; SAMN03472876
DR ChEMBL-Cells; CHEMBL3308130
DR ChEMBL-Targets; CHEMBL1075593
DR Cosmic; 724882
DR Cosmic; 844346
DR Cosmic; 849608
DR Cosmic; 867865
DR Cosmic; 897437
DR Cosmic; 909753
DR Cosmic; 920358
DR Cosmic; 948285
DR Cosmic; 949229
DR Cosmic; 1044244
DR Cosmic; 1113284
DR Cosmic; 1707572
DR Cosmic; 2582804
DR Cosmic-CLP; 909753
DR ECACC; 91091203
DR GDSC; 909753
DR GEO; GSM186459
DR GEO; GSM186460
DR GEO; GSM313714
DR GEO; GSM659406
DR GEO; GSM784571
DR GEO; GSM1670509
DR KCB; KCB 2013039YJ
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6582512;
RX PubMed=10433623;
RX PubMed=11314036;
RX PubMed=23415752;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Caution: Although established from a surgical specimen from a cystadenocarcinoma of the ovary in a 46 year old female Caucasian, it now seems likely that it was established from an ovarian metastasis of a colonic carcinoma (PubMed=10433623).
CC Derived from metastatic site: Ovary.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11 (ATCC; PubMed=25877200)
ST D13S317: 11,12 (Cosmic-CLP)
ST D16S539: 11
ST D18S51: 14
ST D19S433: 14
ST D21S11: 27,29
ST D2S1338: 25
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 10,12 (ATCC; Cosmic-CLP)
ST D7S820: 12 (PubMed=25877200)
ST D8S1179: 11
ST FGA: 21,23
ST Penta D: 9,13
ST Penta E: 7,11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW684
AC CVCL_1726
SY SW-684; SW 684
DR CLO; CLO_0009198
DR EFO; EFO_0002369
DR ATCC; HTB-91
DR BioSample; SAMN03472761
DR ChEMBL-Cells; CHEMBL3308217
DR ChEMBL-Targets; CHEMBL2366143
DR CLS; 300422/p547_SW-684
DR Cosmic; 684075
DR Cosmic; 909754
DR Cosmic; 923379
DR Cosmic-CLP; 909754
DR GDSC; 909754
DR GEO; GSM185154
DR GEO; GSM185155
DR GEO; GSM1670510
DR GEO; GSM1676320
DR GEO; GSM1701653
DR IGRhCellID; SW684
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=26351324;
RX PubMed=27397505;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 10,13
ST D16S539: 11,13
ST D18S51: 14,19
ST D21S11: 30,31.2
ST D3S1358: 15,18
ST D5S818: 12
ST D7S820: 7,10
ST D8S1179: 14
ST FGA: 20,22
ST Penta D: 13
ST Penta E: 14,19
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW690
AC CVCL_1E24
SY SW-690; SW 690
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=994214;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: 34 hours, at 11th passage (PubMed=994214).
CC Derived from metastatic site: Brain.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW691
AC CVCL_0L89
SY SW-691; SW 691
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=3020539;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW707
AC CVCL_6230
SY SW-707; SW 707
DR CLS; 300351/NA
DR Cosmic; 889528
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1000501;
RX PubMed=7459858;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW73.2
AC CVCL_J774
DR ECACC; 93113021
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4342 ! Y3-Ag 1.2.3
CA Hybridoma
//
ID SW732
AC CVCL_F651
SY SW-732; SW 732
DR BioSample; SAMN03151934
RX PubMed=288927;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927, PubMed=20143388).
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW733
AC CVCL_F652
SY SW-733; SW 733
DR BioSample; SAMN03151935
RX PubMed=288927;
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6244232;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927, PubMed=20143388).
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0546 ! SW480
SX Male
CA Cancer cell line
//
ID SW742
AC CVCL_3884
SY SW-742; SW 742
DR BTO; BTO:0002825
DR NCBI_Iran; C146
RX PubMed=1000501;
RX PubMed=17254797;
CC From: Scott and White Clinic; Temple; Texas; USA.
ST Source(s): PubMed=17254797
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 12
ST D16S539: 12
ST D18S51: 13
ST D21S11: 29
ST D3S1358: 15,16
ST D5S818: 13
ST D7S820: 8,9
ST D8S1179: 14
ST FGA: 24
ST TH01: 8
ST TPOX: 11
ST vWA: 16
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW756
AC CVCL_1727
SY SW-756; SW 756
DR CLO; CLO_0009223
DR EFO; EFO_0002370
DR ATCC; CRL-10302
DR BioSample; SAMN03471299
DR ChEMBL-Cells; CHEMBL3308790
DR ChEMBL-Targets; CHEMBL1075594
DR Cosmic; 724839
DR Cosmic; 925359
DR Cosmic; 1131522
DR Cosmic; 1193032
DR Cosmic-CLP; 724839
DR GDSC; 724839
DR GEO; GSM113867
DR GEO; GSM253303
DR GEO; GSM675739
DR GEO; GSM685443
DR GEO; GSM1670511
DR IGRhCellID; SW756
DR IGRhCellID; SW756GEO
RX PubMed=833871;
RX PubMed=3029760;
RX PubMed=6935474;
RX PubMed=7129487;
RX PubMed=15531914;
RX PubMed=27397505;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Characteristics: Contains a complete HPV18 genome.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW780
AC CVCL_1728
SY SW-780; SW 780
DR CLO; CLO_0009199
DR EFO; EFO_0002371
DR ATCC; CRL-2169
DR BioSample; SAMN03473242
DR CCLE; SW780_URINARY_TRACT
DR CCRID; 3131C0001001200025
DR ChEMBL-Cells; CHEMBL3308468
DR ChEMBL-Targets; CHEMBL1075595
DR Cosmic; 687457
DR Cosmic; 1285128
DR Cosmic; 1285990
DR Cosmic; 1819323
DR Cosmic; 2037958
DR Cosmic; 2050464
DR Cosmic; 2057457
DR Cosmic; 2444257
DR Cosmic-CLP; 687457
DR GDSC; 687457
DR GEO; GSM827294
DR GEO; GSM887678
DR GEO; GSM888770
DR GEO; GSM1374936
DR GEO; GSM1574556
DR GEO; GSM1670512
DR IGRhCellID; SW780
RX PubMed=833871;
RX PubMed=6244232;
RX PubMed=6744315;
RX PubMed=7459858;
RX PubMed=22460905;
RX PubMed=24018021;
RX PubMed=24367658;
RX PubMed=25485619;
RX PubMed=25997541;
RX PubMed=27397505;
CC Part of: BLA-40 bladder carcinoma cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9,11
ST D18S51: 15
ST D21S11: 29,30
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 9,10
ST D8S1179: 13
ST FGA: 19,20
ST Penta D: 9
ST Penta E: 12
ST TH01: 6
ST TPOX: 8
ST vWA: 16,19
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW80
AC CVCL_1E58
SY SW-80; SW 80
RX DOI=10.1007/978-1-4757-1647-4_2;
RX PubMed=833871;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C3359; Rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW800
AC CVCL_A684
SY SW-800; SW 800
DR Cosmic; 715816
DR Cosmic; 1016883
DR Cosmic; 2037959
DR GEO; GSM1574555
RX PubMed=833871;
RX PubMed=6244232;
RX PubMed=6744315;
RX PubMed=6935474;
RX PubMed=16885334;
RX PubMed=24018021;
RX PubMed=25997541;
RX PubMed=26621286;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW802
AC CVCL_L214
SY SW-802; SW 802
RX PubMed=833871;
RX PubMed=1000501;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW837
AC CVCL_1729
SY SW-837; SW 837
DR CLO; CLO_0009200
DR CLO; CLO_0009224
DR EFO; EFO_0002372
DR CLDB; cl4447
DR CLDB; cl4448
DR CLDB; cl4972
DR ATCC; CCL-235
DR BioSample; SAMN03472312
DR CCLE; SW837_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308361
DR ChEMBL-Targets; CHEMBL1075596
DR Cosmic; 724852
DR Cosmic; 873707
DR Cosmic; 909755
DR Cosmic; 948839
DR Cosmic; 983734
DR Cosmic; 985589
DR Cosmic; 986021
DR Cosmic; 995397
DR Cosmic; 1043830
DR Cosmic; 1122334
DR Cosmic; 1132696
DR Cosmic; 1184090
DR Cosmic; 1310943
DR Cosmic; 1312316
DR Cosmic; 1374627
DR Cosmic; 1479571
DR Cosmic; 1676728
DR Cosmic; 1708404
DR Cosmic; 1805269
DR Cosmic; 1995655
DR Cosmic; 2302020
DR Cosmic-CLP; 909755
DR ECACC; 91031104
DR GDSC; 909755
DR GEO; GSM817
DR GEO; GSM206554
DR GEO; GSM513925
DR GEO; GSM514315
DR GEO; GSM741265
DR GEO; GSM827281
DR GEO; GSM887679
DR GEO; GSM888771
DR GEO; GSM1346893
DR GEO; GSM1374937
DR GEO; GSM1448195
DR GEO; GSM1670513
DR ICLC; HTL99021
DR IGRhCellID; SW837
DR JCRB; JCRB9115
DR NCBI_Iran; C510
DR SKY/M-FISH/CGH; 2849
RX PubMed=1000501;
RX PubMed=6652615;
RX PubMed=7104989;
RX PubMed=10612807;
RX PubMed=10737795;
RX PubMed=11226274;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/SW837.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 13
ST D16S539: 12
ST D18S51: 17
ST D21S11: 28,31.2
ST D3S1358: 18
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 8,14
ST FGA: 25
ST Penta D: 9,11
ST Penta E: 11,12
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW839
AC CVCL_3604
SY SW-839; SW 839
DR ATCC; HTB-49
DR BioSample; SAMN03472746
DR IZSLER; BS TCL 219
RX PubMed=6244232;
RX PubMed=6935474;
RX PubMed=7459858;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Discontinued: ATCC; HTB-49; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10
ST TH01: 9.3,10
ST TPOX: 9,11
ST vWA: 15,17
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW843
AC CVCL_1E59
SY SW-843; SW 843
RX PubMed=833871;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW850
AC CVCL_A424
SY SW-850; SW 850
DR Cosmic; 736278
DR Cosmic; 933518
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=1906154;
RX PubMed=9472115;
RX PubMed=25997541;
RX PubMed=26621286;
CC Part of: UBC-40 urothelial bladder cancer cell line index.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Omics: SNP array analysis.
CC Caution: Considered by PubMed=25997541 to be a bladder carcinoma cell line. Status is uncertain as other publications mention is a being a pancreatic adenocarcinoma cell line.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW872
AC CVCL_1730
SY SW-872; SW 872
DR BTO; BTO:0003743
DR CLO; CLO_0009201
DR EFO; EFO_0002373
DR ATCC; HTB-92
DR BCRC; 60432
DR BioSample; SAMN03472763
DR ChEMBL-Cells; CHEMBL3308837
DR ChEMBL-Targets; CHEMBL2366302
DR CLS; 300405/p537_SW-872
DR Cosmic; 684521
DR Cosmic; 909756
DR Cosmic; 923383
DR Cosmic; 2009544
DR Cosmic; 2307722
DR Cosmic-CLP; 909756
DR GDSC; 909756
DR GEO; GSM185156
DR GEO; GSM185157
DR GEO; GSM482514
DR GEO; GSM1543668
DR GEO; GSM1543669
DR GEO; GSM1670514
DR IGRhCellID; SW872
DR IZSLER; BS TCL 119
DR NCBI_Iran; C638
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=22911243;
RX PubMed=24726063;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): ATCC; CLS; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 9,12
ST D18S51: 12,16
ST D21S11: 27,31.2
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 8,11
ST D8S1179: 12,15
ST FGA: 21.2,23
ST Penta D: 9,10
ST Penta E: 5,10
ST TH01: 8,10
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3194; Liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW897
AC CVCL_1E60
SY SW-897; SW 897
RX PubMed=833871;
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID SW900
AC CVCL_1731
SY SW-900; SW 900
DR BTO; BTO:0004611
DR CLO; CLO_0009202
DR EFO; EFO_0002374
DR ATCC; HTB-59
DR BioSample; SAMN03472972
DR CCLE; SW900_LUNG
DR ChEMBL-Cells; CHEMBL3308819
DR ChEMBL-Targets; CHEMBL1075597
DR Cosmic; 724879
DR Cosmic; 933582
DR Cosmic; 1071890
DR Cosmic; 1176591
DR Cosmic; 1608837
DR Cosmic; 1995656
DR Cosmic; 2060528
DR Cosmic-CLP; 724879
DR GDSC; 724879
DR GEO; GSM63352
DR GEO; GSM784255
DR GEO; GSM827522
DR GEO; GSM887680
DR GEO; GSM888772
DR GEO; GSM1670515
DR IGRhCellID; SW900
DR KCLB; 30059
RX PubMed=327080;
RX PubMed=833871;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=7736387;
RX PubMed=22460905;
RX PubMed=24135919;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep phosphoproteome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 11
ST D18S51: 19
ST D21S11: 29,31
ST D3S1358: 14
ST D5S818: 11
ST D7S820: 11,12
ST D8S1179: 11,16
ST FGA: 21,23
ST Penta D: 9,12
ST Penta E: 14,15
ST TH01: 8
ST TPOX: 11
ST vWA: 16
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW948
AC CVCL_0632
SY SW-948; SW 948
DR BTO; BTO:0001534
DR CLO; CLO_0009203
DR CLO; CLO_0009225
DR CLO; CLO_0009226
DR EFO; EFO_0002375
DR CLDB; cl4449
DR ATCC; CCL-237
DR BCRC; 60318
DR BioSample; SAMN03473187
DR CCLE; SW948_LARGE_INTESTINE
DR ChEMBL-Cells; CHEMBL3308131
DR ChEMBL-Targets; CHEMBL1075598
DR CLS; 300347/p455_SW-948
DR Cosmic; 724850
DR Cosmic; 876721
DR Cosmic; 909757
DR Cosmic; 934565
DR Cosmic; 948832
DR Cosmic; 995395
DR Cosmic; 1043831
DR Cosmic; 1184094
DR Cosmic; 1223151
DR Cosmic; 1310941
DR Cosmic; 1312317
DR Cosmic; 1466824
DR Cosmic; 1479599
DR Cosmic; 1609501
DR Cosmic; 1676730
DR Cosmic; 1708413
DR Cosmic; 1803952
DR Cosmic; 1995657
DR Cosmic; 2302021
DR Cosmic-CLP; 909757
DR DSMZ; ACC-326
DR ECACC; 91030714
DR GDSC; 909757
DR GEO; GSM206555
DR GEO; GSM513926
DR GEO; GSM514316
DR GEO; GSM741243
DR GEO; GSM784024
DR GEO; GSM887681
DR GEO; GSM888773
DR GEO; GSM1346894
DR GEO; GSM1374938
DR GEO; GSM1374939
DR GEO; GSM1448213
DR GEO; GSM1670516
DR IGRhCellID; SW948
DR NCBI_Iran; C499
RX PubMed=1000501;
RX PubMed=7104989;
RX PubMed=10737795;
RX PubMed=12584437;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=26537799;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Doubling time: 2-4 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep glycome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'SW984' in Cosmic 1184094.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,11
ST D16S539: 11,12
ST D18S51: 19
ST D21S11: 25.2,29
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 9,11
ST D8S1179: 12,14
ST FGA: 24
ST Penta D: 12
ST Penta E: 13
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW954
AC CVCL_1732
SY SW-954; SW 954
DR CLO; CLO_0009204
DR EFO; EFO_0002376
DR ATCC; HTB-117
DR BioSample; SAMN03471097
DR ChEMBL-Cells; CHEMBL3307461
DR ChEMBL-Targets; CHEMBL614943
DR Cosmic; 924247
DR Cosmic-CLP; 924247
DR GDSC; 924247
DR GEO; GSM1670517
DR IGRhCellID; SW954
RX PubMed=27397505;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,11
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 11,13
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 14,15
DI NCIt; C4052; Vulvar squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW962
AC CVCL_1733
SY SW-962; SW 962
DR CLO; CLO_0009205
DR EFO; EFO_0002377
DR ATCC; HTB-118
DR BioSample; SAMN03471098
DR ChEMBL-Cells; CHEMBL3307274
DR ChEMBL-Targets; CHEMBL613530
DR Cosmic; 909758
DR Cosmic-CLP; 909758
DR GDSC; 909758
DR GEO; GSM1670518
DR IGRhCellID; SW962
DR IZSLER; BS TCL 211
RX PubMed=327080;
RX PubMed=6935474;
RX PubMed=27397505;
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,14
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C4866; Vulvar carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SW979
AC CVCL_4057
SY SW-979; SW 979
DR Cosmic; 736279
DR Cosmic; 922261
DR Cosmic; 933520
RX PubMed=833871;
RX PubMed=6935474;
RX PubMed=11169959;
RX PubMed=12800145;
WW http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/SW-979.html
CC From: Scott and White Clinic; Temple; Texas; USA.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID SW982
AC CVCL_1734
SY SW-982; SW 982
DR CLO; CLO_0009206
DR EFO; EFO_0002378
DR ATCC; HTB-93
DR BCRC; 60535
DR BioSample; SAMN03471376
DR BioSample; SAMN03472764
DR CCRID; 3131C0001001200001
DR ChEMBL-Cells; CHEMBL3308534
DR ChEMBL-Targets; CHEMBL2366238
DR CLS; 300404/p703_SW-982
DR Cosmic; 909759
DR Cosmic; 1933188
DR Cosmic; 2009545
DR Cosmic-CLP; 909759
DR GDSC; 909759
DR GEO; GSM1670519
DR GEO; GSM1676321
DR GEO; GSM1701654
DR IGRhCellID; SW982
RX PubMed=833871;
RX PubMed=15038780;
RX PubMed=25485619;
RX PubMed=26351324;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Scott and White Clinic; Temple; Texas; USA.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12,13 (ATCC; Cosmic-CLP; PubMed=25877200)
ST D13S317: 8,12,13 (CLS)
ST D16S539: 11,12
ST D18S51: 16,18
ST D21S11: 28,30
ST D3S1358: 15
ST D5S818: 11,13 (ATCC; CLS; Cosmic-CLP)
ST D5S818: 13 (PubMed=25877200)
ST D7S820: 9,11
ST D8S1179: 11,14
ST FGA: 21,24
ST Penta D: 10,13
ST Penta E: 13,15
ST TH01: 9.3
ST TPOX: 9,11
ST vWA: 19,20
DI NCIt; C3400; Synovial sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Swan 71
AC CVCL_D855
SY SWAN 71; Swan-71
RX PubMed=19766308;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID SWEIG007
AC CVCL_E838
SY SWEIG-H; SWEIG-4H; SWEIG; Sweig
DR dbMHC; 49030
DR ECACC; 88052037
DR IHW; IHW9037
DR IMGT/HLA; 11414
DR PRIDE; PXD001205
RX PubMed=25502872;
WW http://bioinformatics.hsanmartino.it/ecbr/cl37.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: HLA class II peptidome analysis by proteomics.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Swiss SFME
AC CVCL_6459
SY Swiss Serum Free Mouse Embryo
DR CLO; CLO_0009228
DR ATCC; CRL-9391
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID Swiss-LAPA
AC CVCL_0552
SY Swiss-LAP-A
DR MCCL; MCC:0000453
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss19
AC CVCL_1Y75
SY Swiss 19
DR EFO; EFO_0006297
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss2
AC CVCL_1Y76
SY Swiss 2
DR EFO; EFO_0006298
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss20
AC CVCL_1Y77
SY Swiss 20
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss22
AC CVCL_1Y78
SY Swiss 22
DR EFO; EFO_0006299
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss27
AC CVCL_1Y79
SY Swiss 27
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss3
AC CVCL_1Y80
SY Swiss 3
DR EFO; EFO_0006300
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss30
AC CVCL_1Y81
SY Swiss 30
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss38
AC CVCL_1Y82
SY Swiss 38
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss5
AC CVCL_1Y83
SY Swiss 5
DR EFO; EFO_0006301
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss8
AC CVCL_1Y84
SY Swiss 8
DR EFO; EFO_0006302
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID Swiss9
AC CVCL_1Y85
SY Swiss 9
DR EFO; EFO_0006303
RX PubMed=20200519;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID SWLA1
AC CVCL_2725
DR CLO; CLO_0009229
DR ATCC; HB-12559
RX Patent=US6231857;
CC Monoclonal antibody target: Streptococcus mutans cell surface lipooligosaccharide or lipopolysaccharide.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID SWLA2
AC CVCL_2726
DR CLO; CLO_0009230
DR ATCC; HB-12560
RX Patent=US6231857;
CC Monoclonal antibody target: Streptococcus mutans cell surface lipooligosaccharide or lipopolysaccharide.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID SWLA3
AC CVCL_2727
DR CLO; CLO_0009231
DR ATCC; HB-12558
RX Patent=US6231857;
CC Monoclonal antibody target: Streptococcus mutans cell surface lipooligosaccharide or lipopolysaccharide.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID SwR-100
AC CVCL_DD10
SY SwR
RX Patent=US5272070;
RX PubMed=2105319;
RX PubMed=2267628;
RX PubMed=2521484;
CC Selected for resistance to: ChEBI; CHEBI:9367; Swainsonine (Sw).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID SWR/J.Li
AC CVCL_S360
DR ATCC; CRL-6457
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6457; true.
CC Breed/subspecies: SWR/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_6460 ! SWR/J.We
CA Finite cell line
//
ID SWR/J.We
AC CVCL_6460
DR CLO; CLO_0009232
DR ATCC; CRL-6458
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6458; true.
CC Breed/subspecies: SWR/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S360 ! SWR/J.Li
CA Finite cell line
//
ID SWT
AC CVCL_S951
RX PubMed=4760587;
CC Group: Fish cell line.
OX NCBI_TaxID=8084; ! Xiphophorus hellerii
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID SWS-26
AC CVCL_IW65
DR Cosmic; 1312194
RX PubMed=20106510;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SWT-1
AC CVCL_4W76
RX PubMed=8760591;
CC Doubling time: 16.4 +- 2.2 hours (PubMed=8760591).
DI NCIt; C8715; Rhabdoid tumor of the kidney
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SWT-2
AC CVCL_4W77
RX PubMed=8760591;
CC Doubling time: 18.7 +- 1.9 hours (PubMed=8760591).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C8715; Rhabdoid tumor of the kidney
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID SX10
AC CVCL_S163
RX PubMed=7528891;
RX PubMed=11133995;
CC Breed/subspecies: C3H/He.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S164 ! SR-1 [Mouse mammary carcinoma]
SX Female
CA Cancer cell line
//
ID SX9
AC CVCL_D700
SY SX-9
RX PubMed=7528891;
RX PubMed=9582343;
CC Breed/subspecies: C3H/He.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S164 ! SR-1 [Mouse mammary carcinoma]
SX Female
CA Cancer cell line
//
ID SXC1
AC CVCL_D677
SY SXC-1; SXC 1
DR BCRJ; 0230
RX PubMed=2145365;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID SXC2
AC CVCL_J096
SY SXC-2; SXC 2
RX PubMed=2145365;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID SYF
AC CVCL_6461
DR CLO; CLO_0009233
DR ATCC; CRL-2459
RX PubMed=10228160;
CC Knockout cell: Method=KO mouse; MGI; MGI:95602; Fyn.
CC Knockout cell: Method=KO mouse; MGI; MGI:98397; Src.
CC Knockout cell: Method=KO mouse; MGI; MGI:99147; Yes1.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
- 公告/新闻
